{Reference Type}: Journal Article
{Title}: Practical consensus recommendations on ovarian suppression in early breast cancer (adjuvant).
{Author}: Singhal M;Sahoo TP;Aggarwal S;Singhvi A;Kaushal V;Rajpurohit S;Parthasarthi KM;Vora A;Ganvir M;Gupta S;Parikh PM;
{Journal}: South Asian J Cancer
{Volume}: 7
{Issue}: 2
{Year}: Apr-Jun 2018
暂无{DOI}: 10.4103/sajc.sajc_125_18
{Abstract}: Substantial survival benefits exist for patients with early-stage breast cancer who undergo treatment with single-modality ovarian suppression, but its value is uncertain. Expert oncologist discussed to determine whether additional benefits exist with ovarian suppression plus multiple adjuvant therapy which provides a new treatment option that reduces the risk of recurrence in early breast cancer. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at this practical consensus recommendations for the benefit of community oncologists.